Artificial Saliva Market Size, Share, Analysis, Trends, Growth, Forecast (2022-2028)

Artificial Saliva Market Size, Share, Analysis, Trends, Growth, Forecast (2022-2028)

According to a new report published by UnivDatos Markets Insights, the artificial saliva market was valued at more than USD 800 million in 2021 and is expected to grow at a CAGR of around 13% from 2022-2028. The analysis has been segmented into Product Type (Oral Spray, Oral Solution, Oral Liquid, Gel, and Powder); Age Group (Adult and pediatric); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others); and Region/Country

Access sample report (including graphs, charts, and figures): https://univdatos.com/report/artificial-saliva-market/get-a-free-sample-form.php?product_id=41747

The artificial saliva market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the artificial saliva market. The artificial saliva market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the artificial saliva market at the global and regional levels.

Market Overview

Chewing, swallowing, digesting, and speaking all depend on saliva. Additionally, it controls bacteria growth in the mouth & reducing the risk of infection and tooth decay. While primarily water, natural saliva also contains mucous, enzymes, and electrolytes. Although artificial saliva doesn’t exactly like the saliva that our glands normally create, the combination of its ingredients can help relieve symptoms like bad breath and a feeling of dryness or stickiness in the mouth.

Also, doctors may recommend the use of artificial saliva alongside medications and medical treatments, such as pain medications and chemotherapy, that are known to cause dry mouth. For instance, according to the National Cancer Institute (NIH), in 2022, it is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population and it is projected to increase by 24.4%, to 22.5 million, by 2032.

Click here to view the Report Description & TOC https://univdatos.com/report/artificial-saliva-market/

The artificial saliva market is expected to grow at a steady rate of around 13% owing to the increasing prevalence of dysphagia condition in cancer patients. Also, the expensive treatments for oral diseases in both developed & developing countries and the growing disposable income and increasing per-capita spending drive the growth of the market during the forecast period.

Some of the major players operating in the market include GSK plc.; Cipla Inc.; Mission Pharmacal Company; Fresenius Kabi AG; Parnell Pharmaceuticals, Inc.; CCMed Ltd.; ENTOD INTERNATIONAL; Midatech Pharma PLC; Forward Science; Bausch Health Companies Inc.

COVID-19 Impact

The recent covid-19 pandemic has disrupted the world and has brought a state of shock to the global economy. The global pandemic has impacted the healthcare industry and has transformed the way healthcare is delivered. The Artificial Saliva Market has been significantly affected during these times owing to the delay in elective surgeries during the pandemic.

The global artificial saliva market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

·        On the basis of age group, the market is bifurcated into adult and pediatric. Among these, the adult category dominated the growth of the artificial saliva market in 2020. This is mainly due to the artificial saliva being used more by adult patients and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones.

The other factor for the growth of this segment is the growing dysphagia condition due to mouth cancer or oesophageal cancer. For instance, according to the World Cancer Research Fund (WCRF International), around 604,100 new cases of oesophageal cancer were diagnosed in 2020.

·        Based on distribution channel, the artificial saliva market has been classified into hospital pharmacies, retail pharmacies, supermarkets & hypermarkets, and others. The retail pharmacies category is to witness the highest growth during the forecast period. This is mainly due to the affordability of medicines and the growing population with rising cases of diabetes, stroke, Alzheimer’s disease, Sjogren’s syndrome, or HIV/AIDS which will cause dry mouth conditions. For instance, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021.

Have a Look at the Chapters https://univdatos.com/report/artificial-saliva-market/get-a-free-sample-form.php?product_id=41747

Artificial Saliva Market Geographical Segmentation Includes:

·        North America (United States, Canada, and Rest of North America)

·        Europe (Germany, United Kingdom, Spain, Italy, France, and the Rest of Europe)

·        Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific)

·        Rest of the World

North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the availability of major market key players, rising awareness about oral diseases, growing product utilization to treat xerostomia, rising disposable incomes, increasing prevalence of cancer and Alzheimer’s disease, growing technological advancements, and presence of a large patient population in the region, which is expected to aid the market growth. For instance, according to the National Center for Chronic Disease Prevention (CDC), in 2020, as many as 5.8 million Americans were living with Alzheimer’s disease.

The major players targeting the market include

·        GSK plc.

·        Cipla Inc.

·        Mission Pharmacal Company

·        Fresenius Kabi AG

·        Parnell Pharmaceuticals, Inc.

·        CCMed Ltd.

·        ENTOD INTERNATIONAL

·        Midatech Pharma PLC

·        Forward Science

·        Bausch Health Companies Inc.

Competitive Landscape

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Artificial Saliva Market. The major players have been analyzed by using research methodologies for getting insight views on global competition.

Key questions resolved through this analytical market research report include:

• What are the latest trends, new patterns, and technological advancements in the artificial saliva market?

• Which factors are influencing the artificial saliva market over the forecast period?

• What are the global challenges, threats, and risks in the artificial saliva market?

• Which factors are propelling and restraining the artificial saliva market?

• What are the demanding global regions of the artificial saliva market?

• What will be the global market size in the upcoming years?

• What are the crucial market acquisition strategies and policies applied by global companies?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs. 

Related Report

Solar Vehicle Market

Aluminum Casting Market

Plant-Based Ham Market

Pouches Market

Surgical Procedure Volume Market